en ENGLISH
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Filmy Artykuły w druku O czasopiśmie Suplementy Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
3/2021
vol. 123
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
streszczenie artykułu:
Artykuł przeglądowy

Phytocannabinoids and the eye – a systematic review

Anna Wolnik
1
,
Małgorzata Woś
1
,
Jerzy Mackiewicz
2

1.
Division of Ophthalmology with the Children’s Ophthalmology Subunit, Stefan Żeromski Specialist Hospital in Krakow, Poland
2.
Department of Retinal and Vitreous Surgery, Medical University of Lublin, Poland
KLINIKA OCZNA 2021, 123, 3: 114–121
Data publikacji online: 2021/10/13
Pełna treść artykułu
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 


Recently, the use of marihuana for medical purposes has become more common. It can lead to many desired effects within the eye, as well as several adverse ones (i.a.: decrease in intraocular pressure, reduction of corneal pain and suppression of inflammation after chemical injury of cornea, treatment of blepharospasm, reduction of nystagmus, decrease in corneal endothelial cell density, eye irritation). There have not been enough studies with human subjects done on the safety and effectiveness of cannabis use in ophthalmology. Although synthetic cannabinoids combined with modulation of the endocannabinoid system might become the future of ophthalmology, more studies on this topic should be conducted.
facebook linkedin twitter
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.